NEW YORK: Kevin Silverman, director of healthcare innovation at Ruder Finn, died suddenly on Monday at the age of 36.
"The Ruder Finn family is mourning the sudden and devastating loss of our beloved friend and dear colleague, Kevin Silverman," said Ruder Finn CEO Kathy Bloomgarden in a statement. "Kevin’s vibrant spirit, passion and profound kindness deeply touched anyone who knew him. Our most heartfelt condolences go out to his wife, family and friends. He will be greatly missed."
Silverman’s cause of death was not disclosed. On Wednesday afternoon, the firm tweeted a tribute to Silverman.
It is with profound sorrow the RF family mourns the sudden loss of our dear friend and colleague, Kevin Silverman. pic.twitter.com/WvLzCAZ7UW— Ruder Finn (@RuderFinn) October 22, 2014
As director of healthcare innovation, which was a new role when he started at the firm in 2011, Silverman worked to grow the healthcare practice and digital services offered to healthcare clients. He also focused on information management for pharmaceutical companies.
Before his tenure at Ruder Finn, Silverman was VP of digital influence strategy at Ogilvy Public Relations, where his client list included Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. He held various roles at Ogilvy PR between 2002 and 2011, according to LinkedIn, and he also previously worked at Magnet Communications.